Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030141 | γ-linolenic acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 1.17 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | 2.18 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | 1.06 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 1.51 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | 1.48 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 0.89 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 1.74 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 2.14 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | C | 0.0 | BCD100322A001 | 1.13 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | C | 0.5 | BCD100322A003 | 1.87 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | C | 1.0 | BCD100322A007 | 1.23 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | C | 2.0 | BCD100322A011 | 0.86 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | C | 4.0 | BCD100322A015 | 1.18 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | C | 8.0 | BCD100322A019 | 1.51 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | C | 12.0 | BCD100322A023 | 1.8 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | C | 24.0 | BCD100322A027 | 1.12 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 1.69 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 1.23 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | 1.5 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | 0.86 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 2.18 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | 2.77 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 1.18 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol | 0.5 | BCD100322A004 | 1.01 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol | 1.0 | BCD100322A008 | 1.17 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol | 2.0 | BCD100322A012 | 0.72 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol | 4.0 | BCD100322A016 | 1.32 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol | 8.0 | BCD100322A020 | 2.58 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol | 12.0 | BCD100322A024 | 0.96 | pmol/sample |
| LMFA01030141 | γ-linolenic acid | 25OH-Chol | 24.0 | BCD100322A028 | 2.13 | pmol/sample |